High Burden and Persistent Detection of Kodamaea ohmeri Bloodstream Infection Among Neonates in Bangladesh: A Prospective Hospital-Based Surveillance
Authors:
- Tanzir Ahmed ShuvoTSTanzir Ahmed Shuvo
- Sifat Binte IbrahimSISifat Binte Ibrahim
- Nusrat Jahan ShalyNSNusrat Jahan Shaly
- Md. Shoieb Ul HaqueMHMd. Shoieb Ul Haque
- Fahmida Dil FarzanaFFFahmida Dil Farzana
- Farhat JabyFJFarhat Jaby
- Md. Kamrul IslamMd. Kamrul Islam
- Adiba TasnimATAdiba Tasnim
- Shams E. Tabriz BhuiyanSBShams E. Tabriz Bhuiyan
- Nuzhat Shamiha AlamNuzhat Shamiha Alam
- Tasnim Bakir RafaTRTasnim Bakir Rafa
- Laila KabirLKLaila Kabir
Open Access
- 12 November 2026
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 14 (11) , 2624
Abstract
Kodamaea ohmeri is an emerging invasive fungal pathogen, with limited data from low- and middle-income countries. We describe the epidemiology, clinical characteristics, and outcomes of neonatal K. ohmeri bloodstream infection in two tertiary care hospitals in Bangladesh. We conducted prospective surveillance among neonates admitted to neonatal intensive care units of two tertiary care hospitals between August 2022 and June 2026. Fungal isolates were identified using VITEK 2 and confirmed using VITEK MS. Antifungal susceptibility testing (AFST) was performed on a subset of isolates using two gradient diffusion strip tests. Among 770 enrolled neonates, 12.3% (n = 95) had bloodstream infection caused by K. ohmeri, accounting for 27.1% of all positive fungal isolates. Clinical characteristics were comparable between K. ohmeri and other fungal infections. Among the positive K. ohmeri cases, 57.9% (n = 55) received antifungal therapy. AFST showed relatively higher fluconazole MICs than voriconazole, amphotericin B, and echinocandins. However, mortality was numerically lower among patients who received antifungal therapy than among those who did not, although the association was not statistically significant in either unadjusted (p = 0.09) or adjusted (p = 0.065) analyses. The high burden and associated mortality of K. ohmeri bloodstream infections highlight the importance of strengthening species-level fungal identification and antifungal stewardship in resource-limited NICUs. Continued surveillance and further investigations linking antifungal susceptibility with clinical outcomes are warranted to inform evidence-based management.Keywords
Funding Information
- U.S. Centers for Disease Control and Prevention (NU51CK000314)
This publication has 35 references indexed in Scilit:
- Prevalence and Associated Risk Factors of Neonatal Sepsis in a Neonatal Intensive Care Unit of a Tertiary Hospital in Bangladesh: A Cross‐Sectional StudyHealth Science Reports, 2026
- The burden of Neonatal Invasive Candidiasis in Low- and Middle-Income Countries: a systematic review and meta-analysisOpen Forum Infectious Diseases, 2025
- Multimodal strategies for the implementation of infection prevention and control interventions—update of a systematic review for the WHO guidelines on core components of infection prevention and control programmes at the facility levelClinical Microbiology and Infection, 2025
- Neonatal invasive candidiasis in low- and middle-income countries: Data from the NeoOBS studyMedical Mycology, 2023
- Candidiasis and Other Emerging YeastsCurrent Fungal Infection Reports, 2023
- A Cluster of Neonatal Infections Caused by Candida auris at a Large Referral Center in ColombiaJournal of the Pediatric Infectious Diseases Society, 2021
- Changes in the epidemiological landscape of invasive candidiasisJournal of Antimicrobial Chemotherapy, 2018
- Catheter-related bloodstream infection caused by Kodamaea ohmeri: A case report and literature reviewJournal of Infection and Chemotherapy, 2017
- Fungemia due to Kodamaea ohmeri: First isolating in Italy. Case report and review of literatureJournal of Medical Mycology, 2015
- Fluconazole-resistant Kodamaea ohmeri fungemia associated with cellulitis: Case report and review of the literatureInternational Journal of Infectious Diseases, 2009